Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Menopause
Pharma
Europe's CHMP gives nods to Novo's Kyinsu, Bayer's Lynkuet
Europe's CHMP has recommended several products for approval, including Novo Nordisk's diabetes drug Kyinsu and Bayer's menopause treatment Lynkuet.
Kevin Dunleavy
Sep 19, 2025 10:45am
Astellas attacks menopause stigma with new workplace program
Sep 5, 2025 11:02am
FDA delays decision on Bayer's menopause drug elinzanetant
Jul 28, 2025 10:33am
UK regulator approves Bayer's nonhormonal menopause drug
Jul 11, 2025 11:01am
MysteryVibe behind first US billboards to show a sex toy
Mar 26, 2024 12:13pm
Astellas inks deal to air Veozah ad in Super Bowl 2024 coverage
Feb 1, 2024 7:43am
